MDXG
MiMedx Group, Inc
stockNASDAQ
mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.68 | 2026-09-28 | -2.03% | -0.914 |
| 1M | 4.57 | 2026-09-04 | +0.33% | -0.160 |
| 3M | 4.07 | 2026-07-06 | +12.65% | 0.293 |
| 6M | 3.88 | 2026-04-06 | +18.17% | 0.561 |
| 1Y | 7.31 | 2025-10-06 | -37.28% | 0.887 |
| 2Y | 5.76 | 2024-10-04 | -20.40% | — |
| 5Y | 5.86 | 2021-10-05 | -21.76% | 1.203 |
MiMedx Group, Inc (NASDAQ:MDXG) stock price today is $4.59, and today's volume is 1,370,319. MDXG is down 1.185% today. The 30 day average volume is 1.10M. MDXG market cap is $669.11M with 145.93M shares outstanding.